256923-33-8 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
7-FLUORO-4-HYDROXY-3-NITROQUINOLINE is used as a research compound for exploring its potential applications in the development of new drugs. The presence of the fluorine atom enhances the compound's bioavailability and metabolic stability, which are crucial for drug efficacy and safety. The hydroxyl and nitro groups may also contribute to the compound's pharmacological properties, making it a promising candidate for further investigation in various medical conditions.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 7-FLUORO-4-HYDROXY-3-NITROQUINOLINE serves as a key intermediate or building block for the synthesis of more complex molecules with potential therapeutic applications. Its unique structural features allow for the design and optimization of novel drug candidates with improved pharmacokinetic and pharmacodynamic profiles.
Used in Drug Discovery:
7-FLUORO-4-HYDROXY-3-NITROQUINOLINE is employed in drug discovery processes to identify potential lead compounds for the treatment of various diseases. Its structural attributes make it a valuable tool in the search for new therapeutic agents with enhanced efficacy, selectivity, and safety profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 256923-33-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,6,9,2 and 3 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 256923-33:
(8*2)+(7*5)+(6*6)+(5*9)+(4*2)+(3*3)+(2*3)+(1*3)=158
158 % 10 = 8
So 256923-33-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H5FN2O3/c10-5-1-2-6-7(3-5)11-4-8(9(6)13)12(14)15/h1-4H,(H,11,13)
256923-33-8Relevant articles and documents
Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
-
, (2008/06/13)
Thiazolo-, oxazolo- and selenazolo[4,5-c]quinolin-4-amines and analogs thereof are described including methods of manufacture and the use of novel intermediates. The compounds are immunomodulators and induce cytokine biosynthesis, including interferon and/or tumor biosynthesis, necrosis factor, and inhibit the T-helper-type 2 immune response. The compounds are further useful in the treatment of viral and neoplastic diseases.
